BSE filing, NSE: PASUPTAC. Summary written from the filing by ALFA Finder's alert engine.
Pasupati Acrylon Ltd: key numbers
- Share price
- ₹70.25
- Market cap
- ₹626.2 Cr
- Revenue (annual)
- ₹1,010 Cr
- Net profit (annual)
- ₹69.91 Cr
- P/E (TTM)
- 6.5×Sector 52.2×
- Promoter holding
- 65.87%+0.00% QoQ
- FII holding
- 0.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pasupati Acrylon Ltd
All →Pasupati Acrylon Board Meeting Date
Pasupati Acrylon will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended September 2026. The trading window is closed from 1 October to 4 November 2026.
Pasupati Acrylon Other Announcement
Pasupati Acrylon Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Pasupati Acrylon Capacity Expansion
Pasupati Acrylon received approval from the Uttar Pradesh Excise Department to increase its ethanol plant capacity from 180 KL per day to 240 KL per day.
- ethanol plant capacity
- 240.0 KL per day
Pasupati Acrylon Annual General Meeting
Pasupati Acrylon held its 43rd AGM on 9 Sep 2026, adopting FY26 financials, re-appointing a director, and ratifying cost auditor fees. No dividend or capital event was declared.
Pasupati Acrylon Other Announcement
Pasupati Acrylon Limited provided shareholders with a web-link and QR code to access the 43rd Annual Report and AGM Notice. The meeting is scheduled for September 9, 2026.
Pasupati Acrylon Annual Report
Pasupati Acrylon Limited has filed its Annual Report for FY 2025-26. The company's 43rd Annual General Meeting is scheduled for September 9, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.